Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comprehensive analysis of perioperative hypotension in photodynamic diagnosis-assisted transurethral resection of bladder tumor with 5-aminolevulinic acid.
Nohara T, Takimoto A, Shinzawa R, Kurauchi D, Toriumi R, Nakagawa R, Aoyama S, Kamijima T, Kano H, Naito R, Kadomoto S, Iwamoto H, Yaegashi H, Kawaguchi S, Shigehara K, Izumi K, Mizokami A. Nohara T, et al. Among authors: toriumi r. Int J Urol. 2024 Aug;31(8):891-898. doi: 10.1111/iju.15477. Epub 2024 Apr 30. Int J Urol. 2024. PMID: 38687138
Bone Turnover Markers, n-Terminal Propeptide of Type I Procollagen and Tartrate-Resistant Acid Phosphatase Type 5b, for Predicting Castration Resistance in Prostate Cancer.
Kano H, Izumi K, Nakagawa R, Toriumi R, Aoyama S, Kamijima T, Makino T, Naito R, Iwamoto H, Yaegashi H, Kawaguchi S, Shigehara K, Nohara T, Mizokami A. Kano H, et al. Among authors: toriumi r. Biomedicines. 2024 Jan 26;12(2):292. doi: 10.3390/biomedicines12020292. Biomedicines. 2024. PMID: 38397894 Free PMC article.
Procalcitonin in advanced urological cancer-bacterial versus non-bacterial infections: prospective cohort study.
Yaegashi H, Izumi K, Toriumi R, Aoyama S, Kamijima T, Kano H, Makino T, Naito R, Iwamoto H, Kawaguchi S, Nohara T, Shigehara K, Mizokami A. Yaegashi H, et al. Among authors: toriumi r. BMJ Support Palliat Care. 2024 Feb 23:spcare-2023-004758. doi: 10.1136/spcare-2023-004758. Online ahead of print. BMJ Support Palliat Care. 2024. PMID: 38395596
Role of Positive Biopsy Core Ratio in Prostate Cancer Patients.
Kano H, Izumi K, Nakagawa R, Toriumi R, Aoyama S, Kamijima T, Shimada T, Naito R, Kadomoto S, Iwamoto H, Yaegashi H, Kawaguchi S, Nohara T, Shigehara K, Kadono Y, Mizokami A. Kano H, et al. Among authors: toriumi r. Anticancer Res. 2023 Oct;43(10):4619-4626. doi: 10.21873/anticanres.16656. Anticancer Res. 2023. PMID: 37772589
Novel α-Trifluoromethyl Chalcone Exerts Antitumor Effects Against Prostate Cancer Cells.
Shimada T, Naito R, Toriumi R, Nakagawa R, Aoyama S, Kamijima T, Kano H, Kadomoto S, Iwamoto H, Yaegashi H, Izumi K, Kadono Y, Nakata H, Saito Y, Nakagawa-Goto K, Mizokami A. Shimada T, et al. Among authors: toriumi r. Anticancer Res. 2023 Jun;43(6):2433-2444. doi: 10.21873/anticanres.16411. Anticancer Res. 2023. PMID: 37247901
Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20-CCR6 axis.
Kano H, Izumi K, Hiratsuka K, Toriumi R, Nakagawa R, Aoyama S, Kamijima T, Shimada T, Naito R, Kadomoto S, Iwamoto H, Yaegashi H, Kawaguchi S, Nohara T, Shigehara K, Kadono Y, Saito Y, Nakagawa-Goto K, Yoshioka K, Nakata H, Lin WJ, Mizokami A. Kano H, et al. Among authors: toriumi r. Cancer Sci. 2023 Apr;114(4):1479-1490. doi: 10.1111/cas.15683. Epub 2022 Dec 18. Cancer Sci. 2023. PMID: 36479732 Free PMC article.
Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Castration-Sensitive Prostate Cancer.
Iwamoto H, Izumi K, Nakagawa R, Toriumi R, Aoyama S, Kamijima T, Shimada T, Kano H, Makino T, Naito R, Kadomoto S, Yaegashi H, Kawaguchi S, Nohara T, Shigehara K, Kadono Y, Mizokami A. Iwamoto H, et al. Among authors: toriumi r. Biomedicines. 2022 Sep 22;10(10):2369. doi: 10.3390/biomedicines10102369. Biomedicines. 2022. PMID: 36289628 Free PMC article.
18 results